Consent, Privacy, and Patient Rights in Canadian Health Law
This paper examines four interrelated issues in Canadian health law, with a focus on Ontario. It begins by analyzing the Health Care Consent Act's framework for determining patient competence and the legality of treating schizophrenic patients who refuse medication. It then addresses the tension between quality assurance information protection and patient privacy rights under PIPEDA and the Quality of Care Information Protection Act. The paper proceeds to review the Supreme Court of Canada's ruling in the Hassan Rasouli case, exploring who should hold final authority over treatment decisions for incapacitated patients. Finally, it considers the ethical and legal dimensions of informed consent in tumor banking, including the role of blanket consent protocols and the Personal Health Information Act.
- Treating Schizophrenic Patients Who Refuse Medication: Competence framework for forced psychiatric treatment
- Quality Assurance Records and Patient Privacy in Ontario: Balancing QA confidentiality with patient privacy rights
- Substitute Decision-Making and the Rasouli Case: Family vs. medical authority for incapacitated patients
- Informed Consent and Tumor Banking: Ethics and law of banking tissue samples for research
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds each section in specific Canadian statutes and court decisions, giving the analysis a firm legal foundation rather than relying on abstract principles alone.
- Moves logically from individual patient rights (competence, refusal of treatment) to institutional concerns (quality assurance privacy) to family and proxy decision-making, then to research ethics — showing breadth across Canadian health law.
- Balances neutral legal exposition with reasoned normative argument, particularly in the Rasouli discussion where the author defends a clear position on family authority while acknowledging exceptions.
Key academic technique demonstrated
The paper consistently applies a statutory interpretation approach: it identifies the relevant legislation or common law principle, states its operative criteria, and then applies those criteria to the case at hand. This IRAC-adjacent method (Issue, Rule, Application, Conclusion) keeps each section tightly structured and legally rigorous.
Structure breakdown
The paper is divided into four discrete sections, each addressing a distinct health law question. Section one covers competence and coerced treatment under the Health Care Consent Act. Section two examines quality assurance confidentiality under PIPEDA and QCIPA. Section three analyzes the Rasouli Supreme Court decision and argues for family primacy in substitute decision-making. Section four covers the ethics and law of tumor banking, including blanket consent protocols and the Personal Health Information Act.
Treating Schizophrenic Patients Who Refuse Medication
Latha (2010) notes that "legally, treatment without consent is permissible only where common law or statute provides such authority" (p. 96). In the case of a schizophrenic patient who refuses to take prescribed medication, the question comes down to whether the person is legally capable of making a decision. If so, that person has every right to refuse treatment; if not, treatment may be administered. This is the essence of the Health Care Consent Act, which is used to determine whether a schizophrenic patient is capable of deciding for himself (Downie, Caulfield, & Flood, 2011).
The two questions that must be asked under the Health Care Consent Act are: (1) Is the person capable of understanding the information that is relevant to making a decision regarding treatment? (2) Is the person capable of appreciating the likely consequences of refusing or accepting treatment? (Health Care Consent Act, 1996).
If the person is able to do both, that person is deemed capable of making a decision independently, and the state or hospital may not administer treatment against the patient's will. Thus, in the case of a schizophrenic patient who refuses treatment, whether treatment can be forcibly given depends on how these two questions are answered. To administer treatment against a patient's will when that patient is able to understand the information and appreciate the consequences of his choices would be to violate the Health Care Consent Act.
However, if the patient is unable to process information about treatment options, or fails to appreciate the consequences of refusing or accepting treatment, that person may be deemed incompetent and treatment may be administered against his will. In such cases, even if the patient has previously decided not to take treatment, his incompetence allows medical professionals the authority to administer treatment if they deem it necessary for his own safety and for the safety of society.
Thus, the central issue in this process is whether the patient is deemed competent to understand matters regarding his illness and potential treatment. The Health Care Consent Act provides the framework by which this assessment is made, and the law is required to stand by that assessment. To the extent that the patient is able to make an informed decision, the law must respect that right.
A schizophrenic patient who is unable to process information and is clearly unfit to make decisions regarding his safety and the safety of others cannot be expected to act rationally or with sound judgment. In these cases, health care practitioners are responsible for overseeing the patient's condition and have the right to administer treatment. The rights of the patient are placed in the care of the professional provider because it is deemed that the patient cannot be held accountable for his or her own decision-making processes.
Quality Assurance Records and Patient Privacy in Ontario
Information regarding patient care that is reviewed for quality assurance purposes is protected both by information access and privacy legislation in Ontario and by common law across all of Canada. Specifically, it is protected by several Acts. The Personal Information Protection and Electronic Documents Act (PIPEDA) is a federal law impacting all parts of Canada that serves to protect personal information from being shared. There is also the Quality of Care Information Protection Act (QCIPA), which is Ontario law and which "protects the quality assurance/peer review process only if it is conducted by or for a hospital committee designated specifically as a quality of care committee to carry out the functions described by QCIPA" (OHA, 2004).
Additionally, as Cranston and Rozmus (2015) have indicated, "courts have recognized the importance of protecting QA-type records at common law" levels, as evidenced in the Supreme Court case Slavutych v. Baker (1976), in which it was decided that confidentiality is essential in all communications. However, as the Ontario Superior Court decided in Steep v. Scott (2002), "the goal of improving the quality of health care and health services" is given precedence over "any litigation advantage that may accrue to a party by the use of QA-type records" (Cranston & Rozmus, 2015, p. 2). Thus, while laws and court rulings do exist, the basic concept of balancing health quality assurance with privacy rights is one that is constantly being monitored and re-assessed in Ontario.
The aim of this balancing act is to allow and encourage health care providers to learn about and improve upon the ways in which quality assurance can be delivered, and to use data to continuously improve practice. At the same time, the goal is to prevent negligence, respect patient rights, and allow injured parties to pursue legal recourse. Privacy rights matter in Ontario just as much as quality assurance concerns do. The laws that have developed in Ontario and throughout Canada to reflect this need to balance both portions of this societal issue are evidence that the topic is not easily navigated in every instance (Downie, Caulfield, & Flood, 2011).
It is therefore necessary to protect quality assurance information in order to ensure the full involvement of health professionals in quality improvement — but it is equally important to protect the rights of patients and prevent negligence, allowing them legal recourse. The nature of the issue is such that every case must be examined individually and the facts brought to light in order to make a decision in favor of health care professionals or patients. There is no simple solution or sweeping legislation that can serve as a general rule for every case.
References
Cancer View. (2015). Collecting and banking pediatric brain tumor research specimens. Retrieved from http://www.canadiancancertrials.ca/trial/Default.aspx?Trialid=NCT00228748&lang=en
Cranston, D., & Rozmus, A. (2015). Quality assurance records and common law privilege: Balancing competing interests. CBA.org. Retrieved from
Downie, J., Caulfield, T., & Flood, C. (2011). Canadian health law and policy. LexisNexis Canada.
Health Care Consent Act. (1996). Ontario. Retrieved from https://www.ontario.ca/laws/statute/96h02
Latha, K. (2010). The noncompliant patient in psychiatry: The case for and against covert/surreptitious medication. Mens Sana Monographs, 8(1), 96–121.
OHA. (2004). Quality of Care Information Protection Act. OHA. Retrieved from
Petch, J., & Laupacis, A. (2013). Conflict at the end of life: What happens when doctors and families disagree. Healthy Debate. Retrieved from http://healthydebate.ca/2013/11/topic/politics-of-health-care/conflict-at-the-end-of-life
Create your account
Always verify citation format against your institution’s current style guide requirements.